HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Butler, S. A. Articles by Cole, L. A. Search for Related Content PubMed PubMed Citation Articles by Butler, S. A. Articles by Cole, L. A. Related Collections Endocrinology and Metabolism Automation and Analytical Techniques

Detection of Early Pregnancy Forms of Human Chorionic Gonadotropin by Home Pregnancy Test Devices

¹ USA hCG Reference Service, Obstetrics and Gynecology, University of New Mexico, Albuquerque, NM 87131.

^aAddress correspondence to this author at: USA hCG Reference Service, Obstetrics and Gynecology, U.N.M., 2311 Lomas Blvd., NE, Albuquerque, NM 87131. Fax 505-272-6385; e-mail larry{at}hCGlab.com.

Background: Home pregnancy testing devices claim >99% diagnostic accuracy for pregnancy and utility on the first day of the missed menses or earlier. We investigated the forms of human chorionic gonadotropin (hCG) in early pregnancy urines, the diagnostic accuracy claim, and the abilities of 15 devices to detect the different forms of hCG.

Methods: We measured the concentrations of regular hCG and hyperglycosylated hCG (H-hCG, a large hCG variant) in 592 urines. Fifteen home devices were tested according to manufacturers’ instructions with regular hCG and H-hCG diluted in urine.

Results: H-hCG was the principal hCG-related molecule in pregnancy urine in the 2 weeks following the missed menses (61% and 50% of total immunoreactivity in the 4th and 5th completed weeks of pregnancy, respectively). Of 15 home test devices, 2 had a detection limit of 6.3 IU/L for regular hCG, but poorer detection of H-hCG. Two devices detected 13 IU/L regular hCG, one with similar detection and one with poorer detection of H-hCG. Ten devices detected 25 IU/L regular hCG, 6 with poorer detection of H-hCG. One device detected 50 IU/L regular hCG, but better detected H-hCG. Overall, 9 of 15 devices did not detect H-hCG as well as regular hCG.

Conclusions: H-hCG is the principal hCG immunoreactivity in early pregnancy urine. Home tests vary widely in detection limits for regular hCG (6.3–50 IU/L), and 9 of 15 devices (60%) had poorer detection limits for H-hCG than for hCG. The variation in analytical detection limits appears contradictory to the common claim for all devices of >99% detection of pregnancy on the first day of the missed menses or earlier. We suggest that manufacturers calibrate devices for both hCG and H-hCG and determine the detection rates for pregnancy rather than the proportion of positive results at arbitrary hCG concentrations.

The following articles in journals at HighWire Press have cited this article:

				K. L. Scolaro, K. B. Lloyd, and K. L. Helms Devices for home evaluation of women's health concerns Am. J. Health Syst. Pharm., February 15, 2008; 65(4): 299 - 314. [Abstract] [Full Text] [PDF]

				C. S. Sigel and D. G. Grenache Detection of Unexpected Isoforms of Human Chorionic Gonadotropin by Qualitative Tests Clin. Chem., May 1, 2007; 53(5): 989 - 990. [Full Text] [PDF]

				U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu The classification, functions and clinical use of different isoforms of HCG Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784. [Abstract] [Full Text] [PDF]

				R. McChesney, A. J. Wilcox, J. F. O'Connor, C. R. Weinberg, D. D. Baird, J. P. Schlatterer, D.R. McConnaughey, S. Birken, and R. E. Canfield Intact HCG, free HCG {beta} subunit and HCG {beta} core fragment: longitudinal patterns in urine during early pregnancy Hum. Reprod., April 1, 2005; 20(4): 928 - 935. [Abstract] [Full Text] [PDF]

				P. von Lode, J. Rainaho, and K. Pettersson Quantitative, Wide-Range, 5-Minute Point-of-Care Immunoassay for Total Human Chorionic Gonadotropin in Whole Blood Clin. Chem., June 1, 2004; 50(6): 1026 - 1035. [Abstract] [Full Text] [PDF]

				L. A. Cole, J. M. Sutton, T. N. Higgins, and G. S. Cembrowski Between-Method Variation in Human Chorionic Gonadotropin Test Results Clin. Chem., May 1, 2004; 50(5): 874 - 882. [Abstract] [Full Text] [PDF]

				S. F Eichner and E. M Timpe Urinary-Based Ovulation and Pregnancy: Point-of-Care Testing Ann. Pharmacother., February 1, 2004; 38(2): 325 - 331. [Abstract] [Full Text] [PDF]

				G. E. Palomaki, G. J. Knight, M. M. Roberson, G. C. Cunningham, J. E. Lee, C. M. Strom, and R. Pandian Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) in Second-Trimester Maternal Urine as a Marker for Down Syndrome: Preliminary Results of an Observational Study on Fresh Samples Clin. Chem., January 1, 2004; 50(1): 182 - 189. [Abstract] [Full Text] [PDF]

				R. Pandian, J. Lu, and J. Ossolinska-Plewnia Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen) Clin. Chem., May 1, 2003; 49(5): 808 - 810. [Full Text] [PDF]

				J. S. Krouwer Proposal to Add an Optional Recommendations Section to Clinical Chemistry Abstracts Clin. Chem., December 1, 2002; 48(12): 2292 - 2292. [Full Text] [PDF]